Literature DB >> 15352980

The role of PET imaging in lymphoma.

Catherine Burton1, Peter Ell, David Linch.   

Abstract

Positron emission tomography using fluorine-18 (FDG-PET) is increasingly used in the staging and follow-up of malignant lymphomas, although its precise role has not yet been determined. This review considers the results reported at the different stages in the disease history and separately considers the major histological subtypes. Attention is given to the situations in which PET scanning is most likely to influence management. Finally, this review discusses ongoing developments in PET scanning with improved resolution and different radiolabelled tracers.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15352980     DOI： 10.1111/j.1365-2141.2004.05069.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


  16 in total

Review 1.  Development of radiotracers for oncology--the interface with pharmacology.

Authors:  Rohini Sharma; Eric Aboagye
Journal:  Br J Pharmacol       Date:  2011-08       Impact factor: 8.739

2.  Assessment of the nature of residual masses at end of treatment in lymphoma patients using volume perfusion computed tomography.

Authors:  R Syha; L Grünwald; T Horger; D Spira; D Ketelsen; W Vogel; C D Claussen; M Horger
Journal:  Eur Radiol       Date:  2013-12-05       Impact factor: 5.315

3.  [F-18]-Fluoro-2-deoxy-D: -glucose positron emission tomography as a tool for early detection of immunotherapy response in a murine B cell lymphoma model.

Authors:  Coralie Chaise; Emmanuel Itti; Yolande Petegnief; Evelyne Wirquin; Christiane Copie-Bergman; Jean-Pierre Farcet; Marie-Hélène Delfau-Larue; Michel Meignan; Jean-Noël Talbot; Valérie Molinier-Frenkel
Journal:  Cancer Immunol Immunother       Date:  2006-12-14       Impact factor: 6.968

Review 4.  Gastrointestinal follicular lymphoma: review of the literature.

Authors:  Shuji Yamamoto; Hiroshi Nakase; Kouhei Yamashita; Minoru Matsuura; Mariko Takada; Chiharu Kawanami; Tsutomu Chiba
Journal:  J Gastroenterol       Date:  2010-01-20       Impact factor: 7.527

5.  An analysis of the utility of handheld PET probes for the intraoperative localization of malignant tissue.

Authors:  Segundo Jaime González; Lorena González; Joyce Wong; Peter Brader; Maureen Zakowski; Mithat Gönen; Farhad Daghighian; Yuman Fong; Vivian E Strong
Journal:  J Gastrointest Surg       Date:  2010-11-25       Impact factor: 3.452

Review 6.  Role and cost effectiveness of PET/CT in management of patients with cancer.

Authors:  Muhammad Wasif Saif; Ifigenia Tzannou; Nektaria Makrilia; Kostas Syrigos
Journal:  Yale J Biol Med       Date:  2010-06

7.  Role of PET/CT in malignant pediatric lymphoma.

Authors:  Raef Riad; Walid Omar; Magdy Kotb; Magdy Hafez; Iman Sidhom; Manal Zamzam; Iman Zaky; Hussein Abdel-Dayem
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-09-15       Impact factor: 9.236

8.  Role of whole-body [18F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) and conventional techniques in the staging of patients with Hodgkin and aggressive non Hodgkin lymphoma.

Authors:  E Pelosi; P Pregno; D Penna; D Deandreis; A Chiappella; G Limerutti; U Vitolo; M Mancini; G Bisi; E Gallo
Journal:  Radiol Med       Date:  2008-04-14       Impact factor: 3.469

9.  Correlating metabolic activity with cellular proliferation in follicular lymphomas.

Authors:  Bingfeng Tang; Jozef Malysz; Vonda Douglas-Nikitin; Richard Zekman; Regina Heather Wong; Ishmael Jaiyesimi; Ching-Yee Oliver Wong
Journal:  Mol Imaging Biol       Date:  2009-05-09       Impact factor: 3.488

Review 10.  Managing lymphoma with non-FDG radiotracers: current clinical and preclinical applications.

Authors:  Fan-Lin Kong; Richard J Ford; David J Yang
Journal:  Biomed Res Int       Date:  2013-06-06       Impact factor: 3.411
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.